Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02864862 · ClinicalTrials.gov registry record · Phase 4
Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 46
- Enrollment target
NCT02864862: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT02864862 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 46 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02864862, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the esthetic outcomes following immediate implant combined with the autogenous tissue graft or acellular dermal matrix compared to immediate implant alone.
Primary Outcome
Change in ridge dimension is calculated as the value at 6 months minus the value at baseline. To take ridge dimension measurements, impressions were taken at baseline and 6 months, models were made from these impressions, the models were scanned, and then ridge dimension of scanned models was assessed using software. Ridge dimension was assessed at (and at 1mm increments below) the initial soft tissue margin.
Interventions
- DEVICE Immediate implant
- BIOLOGICAL SCTG
- BIOLOGICAL ADM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-10 |
| Est. Completion | 2021-11-22 |
| Phase | Phase 4 |
What the finished NCT02864862 record still lists
NCT02864862 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Immediate implant is the first listed.
NCT02864862 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02864862 about?
NCT02864862 is a clinical study titled "Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation". The purpose of this study is to evaluate the esthetic outcomes following immediate implant combined with the autogenous tissue graft or acellular dermal matrix compared to immediate implant alone.
What is the current status of trial NCT02864862?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 46 participants. The study started on 2016-10. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT02864862?
The interventions under investigation include: Immediate implant (DEVICE), SCTG (BIOLOGICAL), ADM (BIOLOGICAL).
Who is sponsoring clinical trial NCT02864862?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02864862's enrollment target sits among peer trials
46 1348th of 2000 higher than 647 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia